Patents by Inventor Gary Elliot

Gary Elliot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereof
    Patent number: 12616679
    Abstract: The present disclosure provides lyophilates comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate: for subcutaneous administration to a subject, and pharmaceutical compositions, pharmaceutical formulations, and uses thereof
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: May 5, 2026
    Assignee: DRACEN PHARMACEUTICALS, INC.
    Inventors: Steven Dykstra, Gary Elliot, Thomas M. Estok, Stuart R. Gallant, Robert Christian Wild, Jianmin Xu, Henry Acken Havel
  • LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR SUBCUTANEOUS ADMINISTRATION AND THE USE THEREOF
    Publication number: 20230372294
    Abstract: The present disclosure provides lyophilates comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate: for subcutaneous administration to a subject, and pharmaceutical compositions, pharmaceutical formulations, and uses thereof
    Type: Application
    Filed: October 1, 2021
    Publication date: November 23, 2023
    Inventors: Steven DYKSTRA, Gary ELLIOT, Thomas M. ESTOK, Stuart R. GALLANT, Robert Christian WILD, Jianmin XU, Henry Acken HAVEL
  • LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR INTRAVENOUS ADMINISTRATION AND THE USE THEREOF
    Publication number: 20220332676
    Abstract: The present disclosure provides lyophilates comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate: and pharmaceutical compositions, pharmaceutical formulations, and uses thereof.
    Type: Application
    Filed: October 2, 2020
    Publication date: October 20, 2022
    Inventors: Steven DYKSTRA, Gary ELLIOT, Thomas M. ESTOK, Stuart R. GALLANT, Robert Christian WILD, Jianmin XU, Henry Acken HAVEL
  • Therapeutic human anti-IL-1R1 monoclonal antibody
    Patent number: 8710203
    Abstract: Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: April 29, 2014
    Assignees: Amgen Inc., Medarex, L.L.C.
    Inventors: Brian Varnum, Chris Vezina, Alison Witte, Xueming Qian, Francis Hall Martin, Haichun Huang, Gary Elliot
  • Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide- based compounds
    Publication number: 20070225254
    Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.
    Type: Application
    Filed: April 4, 2007
    Publication date: September 27, 2007
    Applicant: Corixa Corporation
    Inventors: David Persing, Richard Crane, Gary Elliot, J. Ulrich, Michael Lacy, David Johnson, Jory Baldridge, Rong Wang
  • IL-17 RECEPTOR LIKE MOLECULES AND USES THEREOF
    Publication number: 20050234221
    Abstract: Novel IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Application
    Filed: March 16, 2001
    Publication date: October 20, 2005
    Inventors: Eugene Medlock, Richard Yeh, Scott Silbiger, Gary Elliot, Hung Nguyen, Shuqian Jing